- Home
- LUNG vs ICG Comparison
LUNG vs ICG Comparison
Compare LUNG & ICG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUNG
- ICG
- Stock Information
- Founded
- LUNG 1995
- ICG 2017
- Country
- LUNG United States
- ICG China
- Employees
- LUNG N/A
- ICG N/A
- Industry
- LUNG Industrial Specialties
- ICG Semiconductors
- Sector
- LUNG Health Care
- ICG Technology
- Exchange
- LUNG Nasdaq
- ICG Nasdaq
- Market Cap
- LUNG 124.0M
- ICG 105.7M
- IPO Year
- LUNG 2020
- ICG 2023
- Fundamental
- Price
- LUNG $2.78
- ICG $2.00
- Analyst Decision
- LUNG Buy
- ICG Strong Buy
- Analyst Count
- LUNG 6
- ICG 2
- Target Price
- LUNG $11.53
- ICG $9.25
- AVG Volume (30 Days)
- LUNG 311.3K
- ICG 231.7K
- Earning Date
- LUNG 07-30-2025
- ICG 08-14-2025
- Dividend Yield
- LUNG N/A
- ICG N/A
- EPS Growth
- LUNG N/A
- ICG N/A
- EPS
- LUNG N/A
- ICG 0.07
- Revenue
- LUNG $87,473,000.00
- ICG $53,729,346.00
- Revenue This Year
- LUNG $18.02
- ICG N/A
- Revenue Next Year
- LUNG $18.17
- ICG $141.94
- P/E Ratio
- LUNG N/A
- ICG $27.09
- Revenue Growth
- LUNG 19.84
- ICG 384.54
- 52 Week Low
- LUNG $2.50
- ICG $1.19
- 52 Week High
- LUNG $9.37
- ICG $12.04
- Technical
- Relative Strength Index (RSI)
- LUNG 41.83
- ICG 53.27
- Support Level
- LUNG $2.52
- ICG $1.57
- Resistance Level
- LUNG $2.84
- ICG $2.21
- Average True Range (ATR)
- LUNG 0.16
- ICG 0.30
- MACD
- LUNG 0.04
- ICG 0.05
- Stochastic Oscillator
- LUNG 46.36
- ICG 80.39
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.
About ICG Intchains Group Limited
Intchains Group Ltd provides integrated solutions consisting of high-performance ASIC chips and ancillary software and hardware for blockchain applications. Its ASIC chips are designed for several key blockchain algorithms including Blake2bsha3, sha512MD160, Cryptonight V4, Eaglesong, Blake2s and others. The company has built a proprietary technology platform named Xihe Platform, which allows the development of a wide range of ASIC chips with high efficiency and scalability. It designs its ASIC chips in-house, which enables it to leverage proprietary silicon data to deliver products reflecting the latest technological developments. Geographically, it operates in Mainland China, Hong Kong, and Other countries or regions.